Form EFFECT 20/20 Biolabs, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 9, 2026 |
| Accession Number: | 0001213900-26-040545 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 9, 2026 |
| Accession Number: | 0001213900-26-040545 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||